Pro Share Advisors LLC Mirati Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $188,199 - $279,587	4,482 New	4,482 $263,000
Q4 2022 Feb 02, 2023	BUY	$41.27 - $98.62 $3,095 - $7,396	75 Added 1.37%	5,550 $251,000
Q3 2022 Nov 04, 2022	BUY	$59.5 - $86.7 $19,694 - $28,697	331 Added 6.43%	5,475 $383,000
Q2 2022 Aug 01, 2022	SELL	$39.16 - $88.71 $67,864 - $153,734	-1,733 Reduced 25.2%	5,144 $345,000
Q1 2022 May 10, 2022	SELL	$75.82 - $150.97 $162,937 - $324,434	-2,149 Reduced 23.81%	6,877 $565,000

Q4 2021 Feb 08, 2022	SELL	$132.01 - $190.29 $407,778 - $587,805	-3,089 Reduced 25.5%	9,026 $1.32 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $379,477 - $509,636	2,872 Added 31.07%	12,115 $2.14 Million
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $1.32 Million - $1.65 Million	-9,196 Reduced 49.87%	9,243 $1.49 Million
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $191,339 - $266,818	1,204 Added 6.99%	18,439 $3.16 Million
Q4 2020 Feb 09, 2021	BUY	$162.05 - $240.27 $884,793 - $1.31 Million	5,460 Added 46.37%	17,235 $3.79 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $22,198 - $32,784	-196 Reduced 1.64%	11,775 $1.96 Million
Q2 2020 Aug 03, 2020	BUY	$72.01 - $120.39 $346,008 - $578,473	4,805 Added 67.05%	11,971 $1.37 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $352,668 - $587,325	-5,054 Reduced 41.36%	7,166 $551,000
Q4 2019 Feb 12, 2020	SELL	$70.76 - $128.86 $107,484 - $195,738	-1,519 Reduced 11.06%	12,220 $1.58 Million
Q3 2019 Nov 12, 2019	BUY	$77.91 - $109.6 $73,547 - $103,462	944 Added 7.38%	13,739 $1.07 Million
Q2 2019 Aug 13, 2019	SELL	$59.49 - $104.71 $90,246 - $158,845	-1,517 Reduced 10.6%	12,795 $1.32 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $50,939 - $92,134	1,167 Added 8.88%	14,312 $1.05 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $420,640 - $623,467	13,145 New	13,145 $558,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account